A permanent birth-control implant called Essure will need to be labeled with a stronger warning that lists potentially serious risks of the device, the Food and Drug Administration announced this week ...

Five months after convening an advisory committee meeting to discuss concerns about the safety of Essure, the only non-surgical permanent contraceptive, the Food and Drug Administration on Monday ...

The new Essure labeling restricts the sale and distribution of the device to only health care providers and facilities that provide information to patients about the risks and benefits of this device.

Federal health regulators plan to warn consumers more strongly about Essure, a contraceptive implant that has drawn thousands of complaints from women reporting chronic pain, bleeding and other health ...

PORTLAND, Ore. - The Food and Drug Administration officially said the birth control product Essure carries serious risks. Despite numerous reports from KATU and other media outlets, the FDA continued ...

Bayer will discontinue the marketing and sales of the sterilization device Essure in all countries outside of the United States, the company announced on Monday. While a number of reports have linked ...

Even though it’s no longer on the market, new data has emerged around potential side effects of the permanent birth control device Essure. The device, pulled from the US market two years ago amid ...

When you shop through retailer links on our site, we may earn affiliate commissions. 100% of the fees we collect are used to support our nonprofit mission. Learn more. Ruth Wilson says it was a group ...

Ducharme is a contributor to TIME. This image provided by Bayer Healthcare Pharmaceuticals shows the birth control implant Essure. Ducharme is a contributor to TIME. Bayer announced Friday that it ...